CATALOGO DEI PRODOTTI DELLA RICERCA

GATTI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.189
EU - Europa 16.424
AS - Asia 11.925
SA - Sud America 1.691
Continente sconosciuto - Info sul continente non disponibili 566
AF - Africa 336
OC - Oceania 25
Totale 50.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.789
RU - Federazione Russa 5.604
SG - Singapore 4.863
GB - Regno Unito 4.075
CN - Cina 3.462
IT - Italia 1.859
BR - Brasile 1.340
DE - Germania 1.063
HK - Hong Kong 1.010
VN - Vietnam 918
SE - Svezia 867
FR - Francia 856
IE - Irlanda 752
FI - Finlandia 608
KR - Corea 380
BD - Bangladesh 250
IN - India 229
UA - Ucraina 219
CA - Canada 192
JP - Giappone 175
TR - Turchia 160
AR - Argentina 118
MX - Messico 99
NL - Olanda 99
NG - Nigeria 88
ID - Indonesia 81
IQ - Iraq 78
PL - Polonia 75
ZA - Sudafrica 72
ES - Italia 67
EC - Ecuador 55
CO - Colombia 53
BE - Belgio 49
PK - Pakistan 44
AT - Austria 38
CL - Cile 37
UZ - Uzbekistan 36
VE - Venezuela 34
SA - Arabia Saudita 29
TG - Togo 28
RO - Romania 26
EG - Egitto 24
BJ - Benin 23
IR - Iran 22
MA - Marocco 21
LT - Lituania 20
PE - Perù 20
KE - Kenya 19
PH - Filippine 19
CH - Svizzera 18
MY - Malesia 18
AU - Australia 17
CZ - Repubblica Ceca 17
JM - Giamaica 17
AE - Emirati Arabi Uniti 15
CR - Costa Rica 15
IL - Israele 14
NP - Nepal 14
PY - Paraguay 14
PT - Portogallo 13
DZ - Algeria 12
HN - Honduras 12
JO - Giordania 12
TN - Tunisia 12
AZ - Azerbaigian 11
BG - Bulgaria 10
AL - Albania 9
BO - Bolivia 9
ET - Etiopia 9
HR - Croazia 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
DO - Repubblica Dominicana 8
EE - Estonia 8
GR - Grecia 8
GT - Guatemala 8
LB - Libano 8
QA - Qatar 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AM - Armenia 7
GE - Georgia 7
NZ - Nuova Zelanda 7
PA - Panama 7
PR - Porto Rico 7
PS - Palestinian Territory 7
RS - Serbia 7
SV - El Salvador 7
UY - Uruguay 7
DK - Danimarca 6
KZ - Kazakistan 6
NI - Nicaragua 6
SN - Senegal 6
BS - Bahamas 5
KW - Kuwait 5
LV - Lettonia 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
KG - Kirghizistan 4
TH - Thailandia 4
Totale 49.519
Salva come PNG Salva come JPEG
Città #
Southend 3.616
Singapore 2.567
Ashburn 2.234
San Jose 1.857
Moscow 1.830
Chandler 1.642
Jacksonville 1.494
Dallas 1.478
Hong Kong 981
Woodbridge 787
Dublin 743
Council Bluffs 721
Ann Arbor 645
Verona 567
Beijing 552
Houston 501
The Dalles 499
New York 371
Los Angeles 335
Wilmington 313
Princeton 305
Lawrence 303
Ho Chi Minh City 292
Jinan 254
Nanjing 217
Shenyang 206
Hanoi 202
Bologna 198
Redmond 190
Santa Clara 184
Buffalo 169
Helsinki 161
Tokyo 160
Milan 144
Munich 140
Tianjin 135
Hebei 133
Sindelfingen 123
São Paulo 121
Redondo Beach 107
Columbus 99
Changsha 93
Abuja 86
Zhengzhou 86
Haikou 85
Ningbo 85
Nanchang 82
San Francisco 76
Orem 75
Boardman 74
Hangzhou 72
Taizhou 72
Guangzhou 69
Chicago 68
Denver 66
London 66
Rome 65
Warsaw 65
Jiaxing 64
Brooklyn 62
Taiyuan 61
Phoenix 59
Seattle 59
Atlanta 58
Falkenstein 57
Turku 57
Washington 53
Toronto 51
Da Nang 48
Montreal 48
Brussels 46
Hyderabad 45
Norwalk 45
Redwood City 45
Frankfurt am Main 44
Boston 43
Falls Church 41
Rio de Janeiro 41
Jakarta 38
Johannesburg 38
Fairfield 37
Brasília 36
Mexico City 36
Tashkent 34
Fuzhou 33
Lanzhou 33
Las Vegas 33
Stockholm 33
Belo Horizonte 32
Chennai 32
Detroit 32
Manchester 31
Poplar 31
Düsseldorf 30
Biên Hòa 29
Haiphong 28
Lomé 28
Seoul 28
Amsterdam 27
Lancaster 27
Totale 30.594
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 358
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 286
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 278
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 273
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 267
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 263
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 257
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 253
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 252
Anti-CCP antibodies and bone 250
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 249
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 246
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 245
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 240
[Therapeutic strategies in osteoporosis: whom and when to treat] 238
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 236
Bone metabolism in patients with anorexia nervosa and amenorrhoea 236
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 234
[Risk factors for hip fracture in elderly persons]. 230
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 224
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 221
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 221
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 221
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 216
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 216
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 215
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 215
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 213
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 213
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 212
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 212
Bone involvement and osteoporosis in mastocytosis. 210
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 210
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 209
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 205
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 205
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 202
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 198
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 198
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 198
Prevalence and incidence of rheumatoid arthritis in Italy. 196
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 195
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 195
Could γ\δ T-cells explain zoledronic acid adverse events? 194
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 193
Association between bone mineral density and serum lipid in men 192
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 191
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 190
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 189
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 189
Guidelines for the diagnosis, prevention and management of osteoporosis 189
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 189
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 188
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 188
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 188
Allergy and the bone: unexpected relationships 186
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 186
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 186
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 186
Rapporti tra sistema immune e metabolismo osseo 185
The obesity paradox and osteoporosis 184
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 183
Osteoporosis treatment: why ibandronic acid? 181
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 181
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 179
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 179
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 178
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 177
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 176
DXA bone mineral density in males: retrospective study in real life. 175
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 175
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 175
Sclerostin and DKK1 in primary hyperparathyroidism. 175
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 175
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 174
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 174
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 174
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 173
Association between environmental air pollution and rheumatoid arthritis flares 172
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 171
Coxibs: a significant therapeutic opportunity. 170
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 170
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 169
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 168
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 167
Invecchiamento dell'apparato scheletrico 167
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 167
Effects of denosumab on peripheral lymphocyte subpopulations 167
GH in combination with bisphosphonate treatment in osteogenesis imperfecta 166
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 166
Association between acute exposure to environmental air pollution and fragility hip fractures 165
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 165
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 164
Artropatie degenerative 164
Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis 164
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 164
Safety issues and adverse reactions with osteoporosis management 163
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 163
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 163
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 162
Totale 19.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.964
article - articoli 172.651
book - libri 0
conference - conferenze 706
curatela - curatele 0
other - altro 329
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.278
Totale 355.928
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.533 0 0 0 111 119 113 37 130 169 65 196 593
2022/20234.908 372 430 477 889 434 1.180 55 262 535 46 167 61
2023/20242.537 106 207 229 306 306 415 111 184 43 100 364 166
2024/20256.683 358 448 296 1.026 347 198 306 298 999 579 533 1.295
2025/202619.356 1.371 996 1.473 3.206 4.687 1.298 1.925 1.103 1.369 957 366 605
2026/20272.674 312 540 819 1.003 0 0 0 0 0 0 0 0
Totale 50.156